{"id":"W4388048048","doi":"10.1136/jitc-2023-sitc2023.0582","title":"582 Analysis of the HR+/HER2- breast cancer tumor microenvironment following immune priming with pelareorep and atezolizumab using imaging mass cytometry – Results from the AWARE-1 trial","year":2023,"lang":"en","type":"article","venue":"Regular and Young Investigator Award Abstracts","topic":"Cancer Research and Treatments","field":"Biochemistry, Genetics and Molecular Biology","cited_by":1,"is_retracted":false,"has_abstract":true,"ca_institutions":"Oncolytics Biotech (Canada)","funders":"","keywords":"Atezolizumab; Medicine; Tumor microenvironment; Breast cancer; Immune system; Oncology; Internal medicine; Antibody; Triple-negative breast cancer; Cancer; Cancer research; Immunotherapy; Immunology; Nivolumab","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0007645444,0.0003241496,0.0005594307,0.0001781697,0.0001571215,0.0005822628,0.0002599251,0.0004922051,0.001497119],"category_scores_gemma":[0.0003724209,0.0002056165,0.0003873145,0.0001437585,0.0002361928,0.0002961787,0.0001751283,0.0007389541,0.0003757193],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0003065501,"about_ca_system_score_gemma":0.0002826532,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0002909071,"about_ca_topic_score_gemma":0.0005287533,"domain_scores_codex":[0.999718,0.00008876373,0.00001846602,0.00006614338,0.00006055626,0.00004803212],"domain_scores_gemma":[0.9997876,0.00004546654,0.00005194923,0.00003356414,0.00002343074,0.00005793498],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"bench_or_experimental","study_design_gemma":"observational","study_design_scores_codex":[0.2631359,0.01837875,0.0934913,0.0005281857,0.0009673962,0.0003078244,0.0002537753,0.002499228,0.4449081,0.0003048585,0.004533242,0.1706914],"study_design_scores_gemma":[0.05579307,0.3069425,0.4143572,0.0000512558,0.00215409,0.001175506,0.0002835807,0.005071896,0.2009741,0.0005771394,0.0125223,0.00009739795],"study_design_candidate":"observational","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9965719,0.0009677231,0.0002992124,0.00008170368,0.0000301346,0.0002940119,0.0004511069,0.00002558864,0.001278527],"genre_scores_gemma":[0.9940445,0.0005566978,0.0009937865,0.0003255214,0.00008018953,0.000474149,0.002167879,0.00001654704,0.001340706],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.001497119,"threshold_uncertainty_score":0.00500834,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.01259663640010753,"score_gpt":0.2596904684011493,"score_spread":0.2470938320010418,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}